QuidelOrtho to Participate in 45th Annual Raymond James Institutional Investor Conference
Recently named Interim Chief Executive Officer,
Interested parties can access the live webcast and replay in the “Events & Presentations” section of the “Investor Relations” page of QuidelOrtho’s website at https://ir.quidelortho.com/.
About
Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed – from home to hospital, lab to clinic. So that patients, clinicians and health officials can spot trends sooner, respond quicker and chart the course ahead with accuracy and confidence.
Building upon its many years of groundbreaking innovation,
For more information, please visit www.quidelortho.com.
Source:
View source version on businesswire.com: https://www.businesswire.com/news/home/20240226717500/en/
Investor Contact:
Vice President, Investor Relations
IR@quidelortho.com
Media Contact:
Communications Manager
media@quidelortho.com
Source: